Valencia Nutrition Limited Receives BSE Listing Approval for 10,90,000 Equity Shares from Warrant Conversion
Valencia Nutrition Limited has received BSE listing approval for 10,90,000 equity shares pursuant to warrant conversion on preferential basis to promoter category. The approval was granted on April 16, 2026, through BSE letter reference LOD/PREF/SS/FIP/83/2026-27. This development represents compliance with SEBI disclosure requirements and marks a significant milestone in the company's capital structure expansion.

*this image is generated using AI for illustrative purposes only.
Valencia Nutrition Limited has secured a significant regulatory milestone with the receipt of listing approval from BSE Limited for equity shares arising from warrant conversion. The approval, dated April 16, 2026, marks an important step in the company's capital structure enhancement.
BSE Listing Approval Details
The company received formal listing approval from BSE Limited through letter reference number LOD/PREF/SS/FIP/83/2026-27. The approval encompasses the following key parameters:
| Parameter: | Details |
|---|---|
| Number of Equity Shares: | 10,90,000 |
| Source: | Conversion of warrants |
| Allotment Basis: | Preferential basis |
| Beneficiary Category: | Promoter Category |
| Approval Date: | April 16, 2026 |
| Reference Number: | LOD/PREF/SS/FIP/83/2026-27 |
Regulatory Compliance
The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions. The warrant conversion and subsequent listing approval falls under this disclosure requirement.
Corporate Structure Impact
The conversion of warrants into equity shares represents a structured approach to capital raising through the preferential route. The warrants were initially allotted to the Promoter Category, indicating internal capital infusion to support business operations and growth initiatives.
Official Communication
The formal intimation was signed by Jay Shah, Whole-Time Director & CFO, bearing DIN 09072405. The communication was digitally signed on April 16, 2026, ensuring authenticity and regulatory compliance. The company has provided a copy of the BSE listing approval as supporting documentation for the disclosure.
Historical Stock Returns for Valencia Nutrition
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -18.85% | -18.33% | +22.12% | -20.53% | +38.04% | +633.26% |
What specific growth initiatives or business expansion plans will Valencia Nutrition fund with the capital raised from this warrant conversion?
How might this increase in promoter shareholding through preferential allotment affect the company's future fundraising strategy and minority shareholder interests?
Will Valencia Nutrition consider additional warrant issuances or explore other capital raising instruments in the near term to support its business objectives?


































